[1] Pan CC, Kavanagh BD, Dawson LA, et al. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys, 2010, 76(Suppl 3):S94-100.
[2] Peixoto A, Pereira P, Bessa de Melo R, et al. Radiation-induced liver disease secondary to adjuvant therapy for extra-hepatic cholangiocarcinoma. Dig Liver Dis,2017, 49(2):227.
[3] Jung J, Yoon SM, Cho B, et al. Hepatic reaction dose for parenchymal changes on Gd-EOB-DTPA-enhanced magnetic resonance images after stereotactic body radiation therapy for hepatocellular carcinoma. J Med Imaging Radiat Oncol,2016, 60(1):96-101.
[4] Guha C, Kavanagh BD. Hepatic radiation toxicity: Avoidance and amelioration. Semin Radiat Oncol,2011, 21(4):256-63.
[5] Feng J, Chen SB, Wu SJ, et al. Quantitative analysis of contrast-enhanced ultrasonography in acute radiation-induced liver injury. Exp Ther Med,2015, 10(5):1807-1811.
[6] Xin TY, Feng J, Chen SB, et al.Application of quantitative analysis of contrast-enhanced ultrasonography in the evaluation of acute radiation-induced liver damage. Exp Ther Med, 2020, 19(4):2957-2962.
[7] Huang CY, Hsieh FS, Wang CY, et al.Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response. Eur J Cancer, 2018, 102:10-22.
[8] Doi H, Masai N, Uemoto K, et al.Validation of the liver mean dose in terms of the biological effective dose for the prevention of radiation-induced liver damage. Rep Pract Oncol Radiother, 2017, 22(4):303-309.
[9] Rahbari NN, Mehrabi A, Mollberg NM, et al. Hepatocellular carcinoma: Current management and perspectives for the future. Ann Surg, 2011, 253(3):453-69.
[10] Li J, Zhou H, Zhang X, et al. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies. Ann Palliat Med, 2020, 9(2):247-255.
[11] Guney IB, Dalci K, Teke Z, et al.A prospective comparative study of ultrasonography, contrast-enhanced MRI and 18F-FDG PET/CT for preoperative detection of axillary lymph node metastasis in breast cancer patients. Ann Ital Chir, 2020.
[12] Tan Z, Teoh WC, Wong KM, et al.Analysis of comparative performance of CEUS and CECT/MR LI-RADS classification: Can CEUS dichotomize LI-RADS indeterminate lesions on CT or MRI? Clin Imaging, 2020, 62:63-68.
[13] Semaan S, Vietti Violi N, Lewis S, et al.Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs.MRI with extracellular contrast vs. gadoxetic acid. Eur Radiol, 2020, 30(2):1020-1030.
[14] Chapman TR, Kumarapeli AR, Nyflflot MJ, et al. Functional imaging of radiation liver injury in a liver metastasis patient: Imaging and pathologic correlation. J Gastrointest Oncol,2015, 6(3):E44-47.
[15] Da Silveira EB, Jeffers L, Schiff ER. Diagnostic laparoscopy in radiation-induced liver disease. Gastrointest Endosc, 2002, 55: 432-434.
[16] Huang Y, Chen SW, Fan CC, et al. Clinical parameters for predicting radiation-induced liver disease after intrahepatic reirradiation for hepatocellular carcinoma. Radiat Oncol, 2016, 11: 89.
[17] Xia H, Deng L, Jin Y. An experimental study on acute radiation-induced liver damage and its protection in rats. J Cancer Control Treat, 2011, 24:9-13.
[18] Benson R, Madan R, Kilambi R, et al. Radiation induced liver disease: A clinical update. J Egypt Natl Canc Inst, 2016, 28: 7-11.
[19] Lee IJ, Seong J, Shim SJ, et al. Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy. Int J Radiat Oncol Biol Phys, 2009, 73: 154-158.
[20] Chu J, Zhang X, Jin L, et al.Protective effects of caffeic acid phenethyl ester against acute radiation-induced hepatic injury in rats. Environ Toxicol Pharmacol, 2015, 39(2):683-689. |